Caption Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$980K Buy
+771,886
New +$1.45M 0.01% 1030
2025
Q1
Sell
-45,137
Closed -$319K 1731
2024
Q4
$319K Buy
45,137
+27,637
+158% +$220K ﹤0.01% 1199
2024
Q3
$142K Buy
+17,500
New +$126K ﹤0.01% 1098
2022
Q2
Sell
-26,344
Closed -$688K 1600
2022
Q1
$688K Buy
26,344
+5,893
+29% +$167K 0.01% 1078
2021
Q4
$811K Buy
20,451
+12,451
+156% +$567K 0.01% 1121
2021
Q3
$400K Hold
8,000
﹤0.01% 1245
2021
Q2
$444K Buy
+8,000
New +$426K 0.01% 1068

Other funds holding HCAT

Caption Management's HCAT Position: Q1 2026 in Review

Caption Management opened a new position in Health Catalyst (HCAT) in Q1 2026: 771,886 shares worth $980K. The stake represents 0.01% of the portfolio and ranks #1030 among its holdings. This is a return to the name: Caption Management previously reported a position in HCAT as recently as Q4 2024.

Caption Management first reported a position in HCAT in Q2 2021 and has held it in 7 quarters since. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Caption Management held 771,886 shares of Health Catalyst worth $980K as of Q1 2026.
  • Health Catalyst was a new Caption Management position in Q1 2026.
  • Health Catalyst made up 0.01% of Caption Management's portfolio in Q1 2026, its #1030 holding.
  • Caption Management first reported a position in Health Catalyst in Q2 2021 and has held it in 7 quarters since.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.